MiRNA-146a is a crucial regulator of immune-related adverse events caused by immune checkpoint inhibitor therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Universität Freiburg, Dissertation, 2020
- Schlagwort
-
Therapeutics
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.6094/UNIFR/167023
- URN
-
urn:nbn:de:bsz:25-freidok-1670231
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2020
Ähnliche Objekte (12)
Immune checkpoint inhibitor induced neurocognitive deficits in patients
The role of the MDM2/p53 axis in anti-tumor immune responses
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Immune modulatory effects of oncogenic KRAS in cancer
Die Rolle von microRNA-146a in dendritischen Zellen bei der akuten Graft-versus-Host-Reaktion
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Immune checkpoint inhibitor induced neurocognitive deficits in patients
The role of the MDM2/p53 axis in anti-tumor immune responses
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Immune modulatory effects of oncogenic KRAS in cancer
Die Rolle von microRNA-146a in dendritischen Zellen bei der akuten Graft-versus-Host-Reaktion
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Immune checkpoint inhibitor induced neurocognitive deficits in patients
The role of the MDM2/p53 axis in anti-tumor immune responses
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Immune modulatory effects of oncogenic KRAS in cancer
Die Rolle von microRNA-146a in dendritischen Zellen bei der akuten Graft-versus-Host-Reaktion
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases